The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice

Journal of Lipid Research

Volumn 47, Issue 9, 2006, Pages 1959-1966

  Kosters, Astrid ^a   Kunne, Cindy ^a   Looije, Norbert ^a   Patel, Shailendra B ^b   Oude Elferink, Ronald P J ^a   Groen, Albert K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bile salt infusion; Canalicular membrane; Diosgenin; Liver

Indexed keywords

BILE SALT; CARRIER PROTEIN; CHOLESTEROL; HETERODIMERIC TRANSPORTER COMPLEX ABCG5; HETERODIMERIC TRANSPORTER COMPLEX ABCG8; TAURODEOXYCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; HYDROPHILICITY; HYDROPHOBICITY; LIVER MEMBRANE; MOUSE; MOUSE STRAIN; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CHOLESTEROL; DIOSGENIN; LIPOPROTEINS; LIVER; MICE; MICE, INBRED C57BL; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID;

EID: 33748754385     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500511-JLR200     Document Type: Article

References (41)

1. Berge, K. E., H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290: 1771-1775.
2. Lu, K., M. N. Lee, S. Hazard, A. Brooks-Wilson, H. Hidaka, H. Kojima, L. Ose, A. F. Stalenhoef, T. Mietinnen, I. Bjorkhem, et al. 2001. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am. J. Hum. Genet. 69: 278-290.
3. Lu, K., M. H. Lee, H. Yu, Y. Zhou, S. A. Sandell, G. Salen, and S. B. Patel. 2002. Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. J. Lipid Res. 43: 565-578.
4. Bhattacharyya, A. K., and W. E. Connor. 1974. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J. Clin. Invest. 53: 1033-1043.
5. Yu, L., J. Li-Hawkins, R. E. Hammer, K. E. Berge, J. D. Horton, J. C. Cohen, and H. H. Hobbs. 2002. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110: 671-680.
6. Yu, L., R. E. Hammer, J. Li-Hawkins, K. von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242.
7. Klett, E. L., K. Lu, A. Kosters, E. Vink, M. H. Lee, M. Altenburg, S. Shefer, A. K. Batta, H. Yu, J. Chen, et al. 2004. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med. 2: 5.
8. Plosch, T., V. W. Bloks, Y. Terasawa, S. Berdy, K. Siegler, F. Van Der Sluijs, I. P. Kema, A. K. Groen, B. Shan, F. Kuipers, et al. 2004. Sito-sterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. Gastroenterology. 126: 290-300.
9. Bloks, V. W., V. M. Bakker-Van Waarde, H. J. Verkade, I. P. Kema, H. Wolters, E. Vink, A. K. Groen, and F. Kuipers. 2004. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia. 47: 104-112.
10. Kamisako, T., and H. Ogawa. 2003. Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatol. Res. 25: 99-104.
11. Kamisako, T., and H. Ogawa. 2003. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats: effects of diosgenin and ethinyl estradiol. Hepatol. Res. 26: 348-352.
12. Kosters, A., R. J. Frijters, F. G. Schaap, E. Vink, T. Plosch, R. Ottenhoff, M. Jirsa, I. M. De Cuyper, F. Kuipers, and A. K. Groen. 2003. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J. Hepatol. 38: 710-716.
13. Kosters, A., R. J. Frijters, C. Kunne, E. Vink, M. S. Schneiders, F. G. Schaap, C. P. Nibbering, S. B. Patel, and A. K. Groen. 2005. Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8. Hepatology. 41: 141-150.
14. Yu, L., S. Gupta, F. Xu, A. D. Liverman, A. Moschetta, D. Mangelsdorf, J. J. Repa, H. H. Hobbs, and J. C. Cohen. 2005. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J. Biol. Chem. 280: 8742-8747.
15. Wittenburg, H., and M. C. Carey. 2002. Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8. J. Clin. Invest. 110: 605-609.
16. Ruetz, S., and P. Gros. 1994. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77: 1071-1081.
17. Ruetz, S., and P. Gros. 1995. Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. Implications for hepatic bile formation. J. Biol. Chem. 270: 25388-25395.
18. Smit, J. J., A. H. Schinkel, R. P. Oude Elferink, A. K. Groen, E. Wagenaar, L. van Deemter, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, M. A. van Roon, et al. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75: 451-462.
19. Lange, Y., C. M. Cohen, and M. J. Poznansky. 1977. Transmembrane movement of cholesterol in human erythrocytes. Proc. Natl. Acad. Sci. USA. 74: 1538-1542.
20. Steck, T. L., J. Ye, and Y. Lange. 2002. Probing red cell membrane cholesterol movement with cyclodextrin. Biophys. J. 83: 2118-2125.
21. Small, D. M. 2003. Role of ABC transporters in secretion of cholesterol from liver into bile. Proc. Natl. Acad. Sci. USA. 100: 4-6.
22. Somjen, G. J., and T. Gilat. 1985. Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J. Lipid Res. 26: 699-704.
23. Somjen, G. J., Y. Marikovsky, P. Lelkes, and T. Gilat. 1986. Cholesterol-phospholipid vesicles in human bile: an ultrastructural study. Biochim. Biophys. Acta. 879: 14-21.
24. Gilat, T., and G. J. Somjen. 1996. Phospholipid vesicles and other cholesterol carriers in bile. Biochim. Biophys. Acta. 1286: 95-115.
25. Crawford, J. M., G. M. Mockel, A. R. Crawford, S. J. Hagen, V. C. Hatch, S. Barnes, J. J. Godleski, and M. C. Carey. 1995. Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J. Lipid Res. 36: 2147-2163.
26. Nibbering, C. P., A. K. Groen, R. Ottenhoff, J. F. Brouwers, G. P. van Berge-Henegouwen, and K. J. Van Erpecum. 2001. Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model. J. Hepatol. 35: 164-169.
27. Meier, P. J., E. S. Sztul, A. Reuben, and J. L. Boyer. 1984. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J. Cell Biol. 98: 991-1000.
28. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
29. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
30. Committee on Enzymes, the Scandinavian Society for Clinical Chemistry and Clinical Physiology. 1974. Recommended methods for the determination of four enzymes in blood. Scand. J. Clin. Lab. lnvest. 33: 291-306.
31. Armstrong, M. J., and M. C. Carey. 1982. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol- solubilizing capacities. J. Lipid Res. 23: 70-80.
32. Amigo, L., H. Mendoza, S. Zanlungo, J. F. Miquel, A. Rigotti, S. Gonzalez, and F. Nervi. 1999. Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt induced hepatic damage. J. Lipid Res. 40: 533-542.
33. Backer, J. M., and E. A. Dawidowicz. 1981. Transmembrane movement of cholesterol in small unilamellar vesicles detected by cholesterol oxidase. J. Biol. Chem. 256: 586-588.
34. Lange, Y., J. Dolde, and T. L. Steck. 1981. The rate of transmembrane movement of cholesterol in the human erythrocyte. J. Biol. Chem. 256: 5321-5323.
35. Leventis, R., and J. R. Silvius. 2001. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys. J. 81: 2257-2267.
36. Schroeder, F., J. R. Jefferson, A. B. Kier, J. Knittel, T. J. Scallen, W. G. Wood, and I. Hapala. 1991. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc. Soc. Exp. Biol. Med. 196: 235-252.
37. Poupon, R., R. Poupon, M. L. Grosdemouge, M. Dumont, and S. Erlinger. 1976. Influence of bile acids upon biliary cholesterol and phospholipid secretion in the dog. Eur. J. Clin. Invest. 6: 279-284.
38. Crawford, A. R., A. J. Smith, V. C. Hatch, R. P. Oude Elferink, P. Borst, and J. M. Crawford. 1997. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. J. Clin. Invest. 100: 2562-2567.
39. Oude Elferink, R. P., R. Ottenhoff, M. van Wijland, C. M. Frijters, C. van Nieuwkerk, and A. K. Groen. 1996. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J. Lipid Res. 37: 1065-1075.
40. Langheim, S., L. Yu, K. von Bergmann, D. Lutjohann, F. Xu, H. H. Hobbs, and J. C. Cohen. 2005. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J. Lipid Res. 46: 1732-1738.
41. Yu, L., K. von Bergmann, D. Lutjohann, H. H. Hobbs, and J. C. Cohen. 2005. Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8. J. Lipid Res. 46: 1739-1744.